Three Japan Firms, AZ In Neglected Disease ‘Booster’ Plan
This article was originally published in PharmAsia News
Executive Summary
The Drugs for Neglected Diseases initiative (DNDi) and four pharmaceutical firms are collaborating on a new project to find therapies for two of the world's most neglected diseases: leishmaniasis and Chagas disease.